After the announcement by the Moderna Inc. (MRNA) (up 9.5 percent), the New York Stock Exchange reached new record highs on Monday in the expectation of a coronavirus vaccine, following very promising results. Like last week’s Pfizer/BioNTech, Moderna has registered more than 90 percent of its candidate vaccine efficacy, and will request its urgent release in the coming weeks. In expectation of a post-Covid economic rebound, the Dow Jones, the S&P 500 and the Russell 2000 ended at all time highs, WTI oil gained 3 percent and the 10-year T-Bond rate rose to 0.90 percent.
The Dow Jones index rose 1.60 percent to 29,950 points at the close, shattering its last high, which was at 29,551 poionts on February 12, prior to the Covid-19 crisis. The S&P 500’s large index rose 1.17% to 3,626 pts, its second high in a row. Rich in technology and biotech stocks, the Nasdaq Composite advanced more modestly by 0.8 percent to 11,924 points (not far from its 12,056 points high, recorded on September 2). The Russell 2000, which covers the American stock market’s small and medium prices, added another 2.25%, a second high after Friday’s and the first since 2018.
The DJIA had climbed 4 percent last week, already powered by the expectation of a vaccine against Covid, and the S&P 500 had gained 2.1 percent. On the other hand, under the weight of the sector rotation that had favored cyclical values rather than ‘technos’ and the internet, the Nasdaq had slowed, yielding 0.5 percent in 5 sessions.
The Boeing Company (BA) jumped 8.17%, Chevron Corporation (CVX) 7.14%, The Walt Disney Company (DIS) 3.5%, Dow Inc. (DOW) 3.77% and American Express Company (AMX) 3.20% inside the Dow Jones. Just 0.3 percent was obtained by Microsoft Corporation (MSFT) and 0.87 percent by Apple Inc (AAPL).